The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Life sciences company Azenta (NASDAQ:AZTA) will be announcing earnings results this Wednesday before the bell. Here’s what you need to know. Azenta beat analysts’ revenue expectations by 1.6% last ...
BURLINGTON, Mass. - Azenta, Inc. (NASDAQ:AZTA) announced Monday that its affiliate, Azenta Germany GmbH, has signed a binding agreement to sell its B Medical Systems business to THELEMA S.À R.L. for ...
Azenta (NASDAQ:AZTA) is preparing to release its quarterly earnings on Tuesday, 2024-11-12. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...
Azenta Life Sciences, a key player in the life sciences industry, is poised for financial recovery with a robust Q2 performance and cost-cutting measures, making it an enticing investment opportunity.
Azenta, Inc., a leading provider of life sciences solutions worldwide, announced that its affiliate, Azenta Germany GmbH, has signed a binding agreement for the sale of Azenta's B Medical Systems ...
Azenta (NASDAQ:AZTA) is set to give its latest quarterly earnings report on Wednesday, 2025-05-07. Here's what investors need to know before the announcement. Analysts estimate that Azenta will report ...
Azenta reported Q2 2025 revenue of $143 million, representing 5% year-over-year growth on a reported basis and 6% on an organic basis. The company achieved a non-GAAP EPS of $0.05 and an adjusted ...
Hosted on MSN
Azenta’s (NASDAQ:AZTA) Q4 CY2025: Beats on revenue
Life sciences company Azenta (NASDAQ:AZTA) reported Q4 CY2025 results , but sales were flat year on year at $148.6 million. Its non-GAAP profit of $0.14 per share was in line with analysts’ consensus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results